Company Overview and News

1
Cannabix Technologies Files FAIMS Cannabis Detection Patent - Enters into License Agreement with University of Florida and Provides Technology Update

2018-04-16 globenewswire
VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK:BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report it has filed a Patent Cooperation Treaty (“PCT”) application titled, “Device and Method for Detection of Cannabis and Other Controlled Substances Using FAIMS” (PCT/CA2017/000042).
Upvote Downvote

 
269 Marijuana Stocks: Correction, Crash, Or Slow Descent?

2018-02-22 seekingalpha
I have been on the planet for 60+ years, and this is starting to look more like a general market “crash” than a “correction”.
Upvote Downvote

1
Cannabix Technologies: 98% Speculation On This Marijuana Stock

2018-01-11 seekingalpha
Cannabix Technologies' (OTCPK:BLOZF) current price is ~$250 million, while its adjusted book value only shows ~$3 million in value. Any perceived value over the $3 million is speculation of BLO's prospects. Because of the uncertainty and low barriers to entry in the marijuana breathalyzer space, I consider a ~$250 million price tag dramatically expensive. Even if BLO is able to bring its breathalyzer to market first, there is no guarantee for long-term success.
Upvote Downvote

1
Horizons Marijuana Life Sciences Index ETF Is A Best Bet For The Passive Marijuana Investor

2018-01-03 seekingalpha
It is always difficult to “pull the trigger” and buy a stock or other financial instrument after a “gap up,” but put this ETF on your “watch list.”.
Upvote Downvote

1
Upcoming Seasonal Anomalies: A Marijuana Stock Focus

2017-11-21 seekingalpha
I was really pleased to see Ted Ohashi focusing on Tax Loss Selling in his most recent Seeking Alpha article, and thought readers might find this article of interest.
Upvote Downvote

1
Cannabix Technologies Inc. Announces Upsize of Previously Announced Bought Deal Private Placement to $4,025,000 and Concurrent Non-Brokered Private Placement of $977,500

2017-11-20 marketwired
Cannabix Technologies Inc. (CSE:BLO)(CSE:BLO.CN)(CNSX:BLO) (the "Company") is pleased to announce that it has amended its agreement with Cormark Securities Inc. (the "Underwriter") and has agreed to increase the size of its previously announced $3.45 million "bought deal" private placement offering. Pursuant to the upsized deal terms, the Underwriter has agreed to purchase, on a "bought deal" basis, 3,500,000 units ("Units") in the capital of the Company, at a price of $1.
Upvote Downvote

1
Cannabix Technologies Inc. Announces $3.45 Million Bought Deal Private Placement

2017-11-17 marketwired
NOT FOR DISTRIBUTION TO UNITED STATED NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES AND DOES NOT CONSTITUTE AN OFFER IN THE UNITED STATES OF THE SECURITIES DESCRIBED HEREIN
Upvote Downvote

 
Dangerous Opinions Spur Need for Cannabis Breathalyzer -- CFN Media

2017-11-09 marketwired
SEATTLE, WA--(Marketwired - Nov 9, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering Cannabix Technologies Inc. (CSE: BLO) (CNSX: BLO) (BLO.CN) (OTCQB: BLOZF), its recent patent filing for a cannabis ignition interlock device, as well as its continued progress in developing a roadside cannabis breathalyzer.
Upvote Downvote

 
Cannabix: Capitalize on Pent-Up Demand for Cannabis Breathalyzer -- CFN Media

2017-08-14 marketwired
SEATTLE, WA--(Marketwired - Aug 14, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) and its upcoming marijuana breathalyzer designed to help law enforcement detect the presence of tetrahydrocannabinol ("THC") at roadside and ultimately prosecute offenders.
Upvote Downvote

 
Cannabix Set to Begin Trials in BC with New Hire -- CFN Media

2017-06-13 marketwired
SEATTLE, WA--(Marketwired - Jun 13, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces an article discussing Cannabix Technologies Inc. (CSE: BLO) (OTCQB: BLOZF) and its efforts to develop a highly sensitive marijuana breathalyzer using its patented FAIMS technology.
Upvote Downvote

 
Cannabix Technologies Adds Dr. David Hasman to Initiate Marijuana Breathalyzer Trials in British Columbia

2017-05-25 marketwired
The Cannabix Marijuana Breathalyzer is being developed to give law enforcement and employers a tool to enforce public safety
Upvote Downvote

 
Competition Heating Up In The Cannabis Breathalyzer Space

2017-05-24 seekingalpha
Cannabix Technologies Inc. has been developing the Cannabix Marijuana Breathalyzer for use by law enforcement and in the workplace.
Upvote Downvote

 
Marijuana & Driving: A Review of the Studies & Legal Challenges -- CFN Media

2017-05-01 marketwired
SEATTLE, WA--(Marketwired - May 1, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces publication of an article discussing the studies for and against marijuana impaired driving, the current state laws regarding per se limits, the challenges for state regulators and law enforcement, and upcoming solutions like Cannabix Technologies' (OTC PINK: BLOZF) cannabis breathalyzer.
Upvote Downvote

 
Cannabix Looks to Solve Roadside THC Testing Issues -- CFN Media

2017-04-12 marketwired
SEATTLE, WA--(Marketwired - Apr 12, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces publication of an article discussing Cannabix Technologies Inc.'s (CSE: BLO) (OTC PINK: BLOZF) recent progress in developing a roadside THC breathalyzer.
Upvote Downvote

 
Live Testing with Cannabix Marijuana Breathalyzer Shows Excellent Sensitivity for THC and Related Metabolites

2017-03-27 marketwired
The Cannabix Marijuana Breathalyzer is being developed to give law enforcement and employers a tool to enforce public safety
Upvote Downvote

BLOZF: Cannabix Technologies (CNSX:BLO) Analysis and Research Report

2018-01-26 - Asif

Cannabix Technologies Inc. is a leader in marijuana breathalyzer development for law enforcement and the workplace. Cannabix has established breath testing technologies in the pursuit of bringing durable, portable hand-held tools to market to enhance detection of marijuana impaired driving offences on roads at a time when marijuana is becoming legal in many global jurisdictions. Cannabix is working to develop drug-testing devices that will detect THC- the psychoactive component of marijuana that causes intoxication- using breath samples. In particular, Cannabix is focused on developing breath testing devices for detection of recent use of THC, in contrast to urine testing for THC metabolite that requires an invasive collection and reflects use days or even weeks earlier. The devices will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous. Recent developments On January 23, 2018 Cannabix Technol...

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

CUSIP: 13765L101